The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
FTO regulates the chemo‐radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β‐catenin through mRNA demethylation
Open accessAbstract
The role of N 6‐methyladenosine (m 6 A) demethylase fat mass and obesity‐associated protein (FTO) in the regulation of chemo‐radiotherapy resistance remains largely unknown. Here, we show that the mRNA level of FTO is elevated in cervical squamous cell carcinoma (CSCC) tissues when compared with respective adjacent normal tissues. FTO enhances the chemo‐radiotherapy resistance both in vitro and in vivo through regulating expression of β‐catenin by reducing m 6 A levels in its mRNA transcripts and in turn increases excision repair cross‐complementation group 1 (ERCC1) activity. Clinically, the prognostic value of FTO for overall survival is found to be dependent on β‐catenin expression in human CSCC samples. Taken together, these findings uncover a critical function for FTO and its substrate m 6 A in the regulation of chemo‐radiotherapy resistance, which may bear potential clinical implications for CSCC treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Jia, G., Fu, Y., Zhao, X., Dai, Q., Zheng, G., Yang, Y., Yi, C., Lindahl, T., Pan, T., Yang, Y.-G., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.687 · Cited by 4,106
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
Zheng, G., Dahl, J. A., Niu, Y., Fedorcsak, P., Huang, C.-M., Li, C. J., Vågbø, C. B., Shi, Y., Wang, W.-L., Song, S.-H., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.015 · Cited by 3,550
A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., Jia, G., Yu, M., Lu, Z., Deng, X., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1432 · Cited by 3,433
Zheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Gene expression regulation mediated through reversible m6A RNA methylation
Fu, Y., Dominissini, D., Rechavi, G., & He, C. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3724 · Cited by 1,935
Fischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Identification of Methylated Nucleosides in Messenger RNA from Novikoff Hepatoma Cells
Desrosiers, R., Friderici, K., & Rottman, F. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.3971 · Cited by 1,757
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N 6 -Methyladenosine RNA Demethylase
Li, Z., Weng, H., Su, R., Weng, X., Zuo, Z., Li, C., Huang, H., Nachtergaele, S., Dong, L., Hu, C., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.11.017 · Cited by 1,508
Self-citationZhang, S., Zhao, B. S., Zhou, A., Lin, K., Zheng, S., Lu, Z., Chen, Y., Sulman, E. P., Xie, K., Bögler, O., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.013 · Cited by 1,459
N6-methyladenosine marks primary microRNAs for processing
Alarcón, C. R., Lee, H., Goodarzi, H., Halberg, N., & Tavazoie, S. F. (2015) · Nature · doi:10.1038/nature14281 · Cited by 1,315
m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
Cui, Q., Shi, H., Ye, P., Li, L., Qu, Q., Sun, G., Sun, G., Lu, Z., Huang, Y., Yang, C.-G., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.059 · Cited by 1,252
Cervical cancer: A global health crisis
Small, W., Bacon, M. A., Bajaj, A., Chuang, L. T., Fisher, B. J., Harkenrider, M. M., Jhingran, A., Kitchener, H. C., Mileshkin, L. R., Viswanathan, A. N., et al. (2017) · Cancer · doi:10.1002/cncr.30667 · Cited by 1,168
Zhang, C., Samanta, D., Lu, H., Bullen, J. W., Zhang, H., Chen, I., He, X., & Semenza, G. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602883113 · Cited by 971
RNA m6A methylation regulates the ultraviolet-induced DNA damage response
Xiang, Y., Laurent, B., Hsu, C.-H., Nachtergaele, S., Lu, Z., Sheng, W., Xu, C., Chen, H., Ouyang, J., Wang, S., et al. (2017) · Nature · doi:10.1038/nature21671 · Cited by 911
Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5
Huang, Y., Yan, J., Li, Q., Li, J., Gong, S., Zhou, H., Gan, J., Jiang, H., Jia, G.-F., Luo, C., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1276 · Cited by 662
N6-Methyl-Adenosine (m6A) in RNA: An Old Modification with A Novel Epigenetic Function
Niu, Y., Zhao, X., Wu, Y.-S., Li, M.-M., Wang, X.-J., & Yang, Y.-G. (2013) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2012.12.002 · Cited by 515
FTO: the first gene contributing to common forms of human obesity
Loos, R. J. F., & Bouchard, C. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00481.x · Cited by 315
Zhang, C., Zhi, W. I., Lu, H., Samanta, D., Chen, I., Gabrielson, E., & Semenza, G. L. (2016) · Oncotarget · doi:10.18632/oncotarget.11743 · Cited by 259
N6-methyl-adenosine modification in messenger and long non-coding RNA
Pan, T. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.12.006 · Cited by 208
Genetic alterations of m6A regulators predict poorer survival in acute myeloid leukemia
Kwok, C.-T., Marshall, A. D., Rasko, J. E. J., & Wong, J. J. L. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0410-6 · Cited by 199
Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells
Pavlopoulou, A., Oktay, Y., Vougas, K. N., Louka, M. A., Vorgias, C. E., & Georgakilas, A. G. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.018 · Cited by 88
Single nucleotide polymorphisms of the FTO gene and cancer risk: an overview
Hernández-Caballero, M. E., & Sierra-Ramírez, J. A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3817-y · Cited by 83
Söderberg, K. C., Kaprio, J. A., Verkasalo, P. K., Pukkala, ., Koskenvuo, M. J., Lundqvist, E., & Feychting, M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.004 · Cited by 83
New Strategies in Advanced Cervical Cancer: From Angiogenesis Blockade to Immunotherapy
Tewari, K. S., & Monk, B. J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1099 · Cited by 83
Tan, A., Dang, Y., Chen, G., & Mo, Z. (2015) · PubMed · Cited by 82
Petrelli, F., Stefani, A. D., Raspagliesi, F., Lorusso, D., & Barni, S. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.04.049 · Cited by 76
Yao, Y., Cui, Y., Qiu, X., Zhang, L., Zhang, W., Li, H., & Yu, J. (2016) · 癌症：英文版 · doi:10.1186/s40880-016-0113-3 · Cited by 72
A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway
Meng, J., Li, P., Zhang, Q., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2088 · Cited by 71
Lurie, G., Gaudet, M. M., Spurdle, A. B., Carney, M. E., Wilkens, L. R., Yang, H., Weiss, N. S., Webb, P. M., Thompson, P. J., Terada, K. Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016756 · Cited by 68
Stone, J., Thompson, D. J., dos‐Santos‐Silva, I., Scott, C. G., Tamimi, R. M., Lindström, S., Kraft, P., Hazra, A., Li, J., Eriksson, L., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2012 · Cited by 66
Breaking the DNA damage response to improve cervical cancer treatment
Wieringa, H. W., van der Zee, A. G. J., de Vries, E. G. E., & van Vugt, M. A. T. M. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.11.008 · Cited by 66
Lin, Y., Ueda, J., Yagyu, K., Ishii, H., Ueno, M., Egawa, N., Nakao, H., Mori, M., Matsuo, K., & Kikuchi, S. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-337 · Cited by 62
Wang, Y., Zhe, H., Gao, P. H., Zhang, N., Li, G., & Qin, J. (2011) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2011.01279.x · Cited by 50
Self-citationNew Strategies for Multimodality Therapy in Treating Locally Advanced Cervix Cancer
Verma, J., Monk, B. J., & Wolfson, A. H. (2016) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2016.05.003 · Cited by 37
Association between the FTOrs8050136 polymorphism and cancer risk: a meta-analysis
Zhao, J., Huang, X., Yang, M., Li, M., & Zheng, J. (2015) · Familial Cancer · doi:10.1007/s10689-015-9843-7 · Cited by 17
Cited by
The role of m6A modification in the biological functions and diseases
Jiang, X., Liu, B., Nie, Z., Duan, L., Xiong, Q., Jin, Z., Yang, C., & Chen, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00450-x · Cited by 2,335
The role of m6A RNA methylation in cancer
Sun, T., Wu, R., & Ming, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108613 · Cited by 963
The interplay between m6A RNA methylation and noncoding RNA in cancer
Ma, S., Chen, C., Ji, X., Liu, J., Zhou, Q., Wang, G., Yuan, W., Kan, Q., & Sun, Z. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0805-7 · Cited by 632
The role of m6A modification in physiology and disease
Yang, C., Hu, Y., Zhou, B., Bao, Y., Li, Z., Gong, C., Yang, H., Wang, S., & Xiao, Y. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03143-z · Cited by 200
Metadata
- Authors
- Zhou, S., Bai, Z., Xia, D., Zhao, Z., Zhao, R., Wang, Y., & Zhe, H.
- Venue
- Molecular Carcinogenesis
- Publisher
- Wiley
- Published
- 2018-02
- Volume
- 57
- Issue
- 5
- Pages
- 590-597
- ISSN
- 0899-1987 (ISSN-L)
- 1098-2744
- OpenAlex
- W2784196060
- Cited by
- 365
- References
- 35
- FWCI
- 13.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
